Amneal Pharmaceuticals Depreciation & Amortization 2011-2026 | AMRX

Annual Depreciation & Amortization Amneal Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
62.6 M	66.2 M	68.1 M	60.7 M	60.4 M	63.3 M	64.4 M	42 M	29.3 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
68.1 M	29.3 M	57.4 M

Quarterly Depreciation & Amortization Amneal Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
39.6 M	45.8 M	45.2 M	43.3 M	40.1 M	39.9 M	40.6 M	40.8 M	41.1 M	-	44.5 M	42 M	40.9 M	-	43.8 M	43.5 M	41.7 M	-	44.5 M	44 M	42.6 M	-	38 M	34.8 M	31 M	-	17.4 M	15.5 M	1.76 M	-	10.7 M	9.65 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
45.8 M	1.76 M	35.5 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 80.34	-	$ 1.55 B	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	1.13 M	$ 0.84	1.96 %	$ 4.58 M	China
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Adagene ADAG	723 K	$ 2.67	-	$ 150 M	China
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.58 M	$ 1.5	-	$ 281 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Cabaletta Bio CABA	1.43 M	$ 2.44	-	$ 2.85 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.22	-	$ 9.18 B	Israel
Autolus Therapeutics plc AUTL	7.55 M	$ 1.46	-	$ 373 M	Britain
Compugen Ltd. CGEN	461 K	$ 1.71	-	$ 153 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel